
New research reveals that discontinuing long-term benzodiazepine therapy may increase risks of mortality and other adverse outcomes, challenging common assumptions.
Dr Sutherland is a first-year psychiatry resident at Creighton University in Omaha, Nebraska.

New research reveals that discontinuing long-term benzodiazepine therapy may increase risks of mortality and other adverse outcomes, challenging common assumptions.

Published: April 16th 2025 | Updated: